ANAIS MALPICA to Mutation
This is a "connection" page, showing publications ANAIS MALPICA has written about Mutation.
Connection Strength
0.215
-
Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations. Sci Rep. 2020 11 26; 10(1):20678.
Score: 0.045
-
Mesonephric-like Carcinoma of the Endometrium: A Subset of Endometrial Carcinoma With an Aggressive Behavior. Am J Surg Pathol. 2020 04; 44(4):429-443.
Score: 0.043
-
The molecular pathology of ovarian serous borderline tumors. Ann Oncol. 2016 04; 27 Suppl 1:i16-i19.
Score: 0.032
-
KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma. J Pathol. 2013 Dec; 231(4):449-56.
Score: 0.028
-
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas. Am J Pathol. 2010 Oct; 177(4):1611-7.
Score: 0.022
-
Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors. J Transl Med. 2022 12 17; 20(1):606.
Score: 0.013
-
Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements. Clin Cancer Res. 2022 04 14; 28(8):1724-1733.
Score: 0.012
-
The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes. Gynecol Oncol. 2022 06; 165(3):560-567.
Score: 0.012
-
Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review. Gynecol Oncol. 2015 Dec; 139(3):568-72.
Score: 0.008